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Profilin is a small (12–15 kDa) actin binding protein which promotes filament turnover. Profilin is also involved in the signaling pathway
linking receptors in the cell membrane to the microfilament system within the cell. Profilin is thought to play critical roles in this signaling
pathway through its interaction with phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] and phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P3]
(P.J. Lu, W.R. Shieh, S.G. Rhee, H.L. Yin, C.S. Chen, Lipid products of phosphoinositide 3-kinase bind human profilin with high affinity,
Biochemistry 35 (1996) 14027–14034). To date, profilin's interaction with polyphosphoinositides (PPI) has only been studied in micelles or small
vesicles. Profilin binds with high affinity to small clusters of PI(4,5)P2 molecules. In this work, we investigated the interactions of profilin with
sub-micellar concentrations of PI(4,5)P2 and PI(3,4,5)P3. Fluorescence anisotropy was used to determine the relevant dissociation constants for
binding of sub-micellar concentrations of fluorescently labeled PPI lipids to profilin and we show that these are significantly different from those
determined for profilin interaction with micelles or small vesicles. We also show that profilin binds more tightly to sub-micellar concentrations of
PI(3,4,5)P3 (KD=720 μM) than to sub-micellar concentrations of PI(4,5)P2 (KD=985 μM). Despite the low affinity for sub-micellar concentration
of PI(4,5)P2, profilin was shown to bind to giant unilamellar vesicles in presence of 0.5% mole fraction of PI(4,5)P2 The implications of these
findings are discussed.
© 2006 Elsevier B.V. All rights reserved.Keywords: Fluorescence spectroscopy; Anisotropy; Lifetime; FRET; PIP; GUV1. Introduction
Profilin, a small ubiquitous non-muscle protein of 12–
15 kDa, is found in eukaryotic cells [1,2], plants [3] and viruses
[4]. Although profilin has been intensively studied since its
discovery more than 20 years ago, its in vivo function is still
poorly understood. In 1994, Haugwitz et al. [5] demonstrated
that profilin is essential for the normal development and
cytokinesis of Dictyostelium amoeba. They showed that in a
profilin null mutant the motility of cells was significantlyAbbreviations: PI(4,5)P2, phosphatidylinositol 4,5-bisphosphate; PI(3,4,5)
P3, phosphatidylinositol 3,4,5-trisphosphate; PPI, polyphosphoinositides; GUV,
giant unilamellar vesicles
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doi:10.1016/j.bbamem.2006.12.012reduced and that the development was blocked prior to fruiting
body formation. Furthermore, these cells could not be grown in
shaking culture under normal conditions [5]. Profilin 1 is also
essential for cell survival and cell division in mice [6]. Witke
et al. showed that homozygous profilin null mutant (pfn1ko/ko)
mice are not viable [6]. Indeed, pfn1ko/ko embryos died as early as
the two-cell stage and no pfn1ko/ko blastocysts were detectable.
The binding of profilin to actin monomers is probably one of
the functions that have received the most attention in the last
decade. Profilin binds actin monomers with a dissociation
constant of 0.35–5 μM [7,8]. Together with cofilin, profilin
promotes filament turnover. Profilin catalyses the exchange of
nucleotides (ADP for ATP) in the actin cleft and prevents
hydrolysis of bound ATP [8–10]. Profilin can facilitate actin
polymerization by transporting monomers to the fast growing
ends of filaments. However, in the current model of filamentous
440 P.D.J. Moens, L.A. Bagatolli / Biochimica et Biophysica Acta 1768 (2007) 439–449actin, profilin and actin compete for the same binding site.
Therefore, to add monomers to the growing end of the filament,
profilin must either move to a new site on actin or completely
dissociate (reviewed in [11]).
In Saccharomyces cerevisiae, profilin partitions between the
plasma membrane and the cytosol in response to membrane
phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] levels. At
rest, 80% of the profilin is associated with membrane
phospholipids [12]. In resting platelets, Hartwig et al. [13]
showed that 36% of the cell profilin is associated with the cell
membrane. Upon activation by thrombin, these authors noted an
increase of the fraction of profilin associated with the membrane
to between 41 and 52%. Due to the interaction of profilin with
PI(4,5)P2 and phosphatidylinositol 3,4,5-trisphosphate [PI
(3,4,5)P3], profilin is thought to play critical roles in signaling
pathways between the cell membrane and the cytoskeleton
[14,15]. It is also well known that PI(4,5)P2 micelles dissociates
profilin from actin [16] and that profilin isolated from platelets
binds with high affinity to small clusters of PI(4,5)P2 molecules
[17].
Profilin's binding to PI(4,5)P2 micelles or small vesicles was
studied using gel filtration [7,12,15,17], micro filtration [7],
centrifugation [12] and fluorescence intensity measurements
[15,18]. However, the dissociation constants reported vary by
>200-fold (0.13 μM [12] to 35 μM [15]).
The exact binding region on profilin for polyphosphoinosi-
tides (PPI) is still not known. In 2002, Lambrechts et al. [7] and
Skare and Karlsson [19] suggested the presence of two binding
regions for PI(4,5)P2 on human and mammalian profilin 1. One
binding region is close to the binding site of poly (L-proline) and
spans residues 126–136. The other includes residue 88 and
overlaps with the actin-binding surface. Therefore, binding of
PPI to the region spanning residues 126–136 allows for the
formation of a ternary complex of actin:profilin:PPI, while
binding of PPI to the region including residue 88 results in the
dissociation of the profilin:actin complex.
The binding stoichiometry of PI(4,5)P2 to profilin ranges
from 5:1 in large unilamellar vesicles produced by the extrusion
technique (LUVET), to 10:1 in micelles [14,15]. Goldschmidt-
Clermont et al. suggested that this difference in binding
stoichiometry could be due to steric hindrance among profilin
molecules binding to micelles. This steric hindrance would
result in an overestimation of the number of PI(4,5)P2
molecules bound per profilin. They also suggested that profilin
aggregates PI(4,5)P2 into small patches [17].
The organization of PI(4,5)P2 in cell membrane is clearly
different from the organization of PI(4,5)P2 in micelles and
therefore, the binding of profilin to the membrane PI(4,5)P2
could be different. It is possible that the initial binding of
profilin starts with a single molecule of PI(4,5)P2 which could
be followed by a recruitment of additional PI(4,5)P2 molecules
by profilin forming small aggregates of PI(4,5)P2 lipids.
Alternatively, the initial binding of profilin to the membrane
PI(4,5)P2 could require the presence of small clusters of PI(4,5)
P2 lipids. In this paper, we investigate this question by studying
the interaction of profilin with sub-micellar concentrations of
PPI lipids and show that the binding of profilin to sub-micellarconcentration of PPI is significantly weaker than the binding of
profilin to PI(4,5)P2 in micellar form or LUVET. However, we
also observed binding of profilin to Giant unilamellar vesicles
(GUV) containing only 0.5% of PI(4,5)P2. Our FRET data
suggest that the binding of profilin to the GUV recruits
neighboring PI(4,5)P2 molecules, stabilizing its interaction with
the lipid membrane. We also show that the KD of profilin for
mono-dispersed PI(3,4,5)P3 is lower than the KD for mono-
dispersed PI(4,5)P2 [15].
2. Materials and methods
2.1. Polyphosphatidylinositols and lipids
Labeled PPI, i.e. BODIPY® TMR PI(4,5)P2, BODIPY® TMR PI(3,4,5)P3,
BODIPY® FL PI(4,5)P2, were purchased from Molecular Probes, Inc (Eugene,
OR) or Echelon Biosciences, Inc (Salt Lake City, UT). Unlabeled L-α-
Phosphatidylinositol-4,5-bisphosphate (Brain, Porcine-Triammonium Salt) and
1-palmitoyl 2-oleoyl-phosphatidylcholine (POPC) were purchased from Avanti
Lipids, Inc (Alabaster, AL).
Homogeneous micelles of unlabeled PI(4,5)P2 were prepared according to
the procedure described by Goldschmidt-Clermont et al. [17]. Briefly, 1 mg of PI
(4,5)P2 per ml of MilliQ water was sonicated for 5 min at room temperature in a
Bransonic Ultrasonic cleaner Model 2200.
2.2. Profilin cloning and purification
Profilin was purified from outdated human platelets as described in Janmey
[20]. Human profilin 1 cDNA (MGC Clone ID: 3896948) was purchased from
Invitrogen (Carlsbad, CA). Profilin cDNA was cut from the pCMV SPORT 6
vector using the restriction endonucleases NcoI and XhoI and was cloned into a
pETBlue-2 vector (Novagen). The pETBlue-2 vector containing the profilin
cDNAwas transformed into the Rosetta 2(DE3)pLacI bacterial strain (Novagen)
for expression and purification. Cells were lysed using 5 ml/g of wet cells of
BugBuster HT reagent (Novagen). The cell lysate was then loaded on a poly-L
proline affinity column and profilin was eluted using the same procedure as the
one used for profilin isolated from human platelets. The purified profilin was
renatured by extensive dialysis in 50 mM Tris buffer pH 7.
2.3. Spectroscopy
Light scattering, steady state anisotropy, Förster resonance energy transfer
(FRET) and fluorescence lifetime measurements were carried out on an ISS K2
multifrequency phase and modulation spectrofluorometer (ISS, Inc., Cham-
paign, IL) equipped with a 300 W Xenon arc lamp. Dynamic light scattering
measurements were obtained on a Brookhaven PCS with a BI9000 correlator.
The light source was a Spectra Physics 35 mW He/Ne laser at 632.8 nm.
2.3.1. Light scattering
The intensity of scattered light from 1 μM to 1 mM solutions of PI(4,5)P2
was measured in a 4×10 mm cuvette using an excitation wavelength of 330 nm
or 350 nm and looking at the light scattered at a 90° angle at the same
wavelength as the excitation—the cuvettes were oriented with the shortpath
towards the excitation source. During the measurements the intensity was
corrected for the fluctuation of the exciting light using Rhodamine B in ethanol
as a quantum counter. The average excitation counts obtained during the
measurement was then used to normalize the scattering intensity between
different samples and therefore compensate for changes in the excitation light
between measurements. The intensity obtained was then corrected for the
dilution of the PI(4,5)P2 in each of the samples.
2.3.2. Fluorescence anisotropy
Excitation of the BODIPY® TMR PPI was at 540 nm and excitation of the
BODIPY® FL PI(4,5)P2 was at 505 nm. Fluorescence emission was recorded at
wavelengths greater than 570 nm, observed through a Melles Griot Schott glass
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Subtractions of blank samples containing the same concentration of profilin
as the PPI samples were performed for each measurement. In each sample,
the labeled PPI concentration was kept constant at 1 μM. The anisotropy of
the sample was recorded at a controlled temperature of 20±0.1 °C. The
concentration of each of the profilin solution was determined from absorption
measurements on a Shimadzu UV-2450 dual beam spectrophotometer using a
profilin molar extinction coefficient of ε280
cm−1=18140. The OD measurements
of the profilin samples containing labeled BODIPY® TMR PPI or BODIPY®
FL PI(4,5)P2 were corrected for the contribution of the labeled PPI at
280 nm.
Anisotropy can be used to determine the dissociation constant of proteins
with their ligands [21] Because of the additive property of the anisotropy, the
observed anisotropy (r) of a solution containing protein (P) and ligand (L) is
given by:
r ¼ fFrF þ fBrB ð1Þ
where fF and rF are the fraction and anisotropy of the ligand free in solution,
respectively and fB and rB are the fraction and anisotropy of the ligand bound to
the protein, respectively. The dissociation constant is given by:
KD ¼ ½Pd½L=½PL ð2Þ
The fraction of the ligand in the bound form can be obtained from:
fB ¼ ½PL=½PL þ ½L ¼ ½P=½P þ KD ð3Þ
Eq. (1) can be rearranged to yield:
fB ¼ r  rF=rB  rF ð4Þ
where rF is obtained by measuring the anisotropy of the ligand in the absence of
protein and rB is measured in presence of a high protein concentration, adequate
to bind all ligands. The measured values of r can be used to calculate fB and fF
and subsequently the dissociation constant for the reaction. One should note that
Eq. (4) assumes that there is no change in the quantum yield upon binding which
is the case in this study. This is demonstrated by the absence of changes in the
lifetime of BODIPY® fluorophores in presence or absence of profilin (Fig. 1).
2.3.3. Förster Resonance Energy Transfer (FRET)
FRET was measured between the BODIPY® FL probes attached to
PI(4,5)P2 excited at 470 nm and the BODIPY® TMR probes attached to
PI(4,5)P2. The FRET efficiency was determined from steady state intensity
measurements looking at both the decreased intensity of the donor probe
(BODIPY® FL) and the enhancement of the fluorescence intensity of the
acceptor probe (BODIPY® TMR). The excitation and emission slits were set atFig. 1. Multifrequency phase and modulation data obtained for 1 μMBODIPY®
TMR PI(4,5)P2 in presence and absence of profilin. The filled symbols are the
phase (●) and modulation (■) data, respectively, measured for BODIPY® TMR
PI(4,5)P2 in absence of profilin. The open symbols represent the phase (○) and
modulation (□) data, respectively, determined for BODIPY® TMR PI(4,5)P2 in
presence of 733 μM profilin. The solid lines are the fit of the phase and
modulation data.4 nm. The Förster distance (distance where the efficiency of transfer is 50%) was
calculated using:
R0 ¼ 0:2108ðn4Qdj2JÞ1=6 A° ð5Þ
where n is the refractive index of the medium, Qd is the quantum yield of the
donor probe. For BODIPY® FL we used a value of 0.9 [22]. κ2 is the orientation
factor and is assumed to be 2/3 [23]. J is the overlap integral between the
fluorescence emission spectrum of the BODIPY® FL PI(4,5)P2 and the
absorption spectrum of BODIPY® TMR PI(4,5)P2. Using Eq. (5), we calculated
an R0 value for the probe pair of 74 Å.
The efficiency of transfer (E) is related to the distance separating the two
probes by:
E ¼ R60=R60 þ R6 ð6Þ
where R is the distance separating the donor and acceptor probes.
In a solution containing different arrangements of donor acceptor probes, the




where δk is the probability for the kth arrangement of donor–acceptor probes
and Ek the efficiency of transfer for that particular arrangement. The probability
δk is a function of the acceptor molar fraction (0.5 in this case).
2.3.4. Fluorescence lifetime determinations
The lifetimes of the fluorophores were determined using glycogen scattering
as the temporal reference (0 ns). The BODIPY® FL probes were excited at
505 nm while BODIPY® TMR probes were excited at 540 nm. The excitation
bandwidth was set to 16 nm. The emission of BODIPY® FL was observed at
wavelengths greater than 550 nm through a Melles Griot Schott glass type
OG530 cut-off filter and that for BODIPY® TMR was observed at wavelengths
greater than 590 nm through a Schott glass type OG570 cut-off filter. The
exciting light was polarized vertically (0 °) and the emission polarizer was set to
the magic angle (55 °). The phase and modulation data were fit using the Globals
software available from the Laboratory for Fluorescence Dynamics at the
University of California at Irvine.
2.3.5. Dynamic light scattering
Dynamic light scattering experiments were performed at 25 °C. Detection of
the scattered light was performed at 90 ° angle. Prior to dissolving the PI(4,5)P2,
the Milli-Q water was filtered using whatman anatop syringe filters (pores
diameter of 0.02 μm). After dilution, the samples were sonicated for 5 min in a
Bransonic Ultrasonic cleaner.
2.4. Giant unilamellar vesicles (GUVs)
GUV's were prepared using the electroformation method first described by
Angelova et al. [24]. The vesicles were formed using POPC and varying amount
of PPI lipids (from 0.01% to 10%) on Pt wire electrodes in special chambers
described in Fidorra et al. [25]. The lipid mixture was deposited on the Pt wire
surface (3 μl of a 0.2 mg/ml lipid stock solution in Cl3CH/MetOH 2:1 v/v). The
sample was then placed under vacuum to remove traces of organic solvent. The
vesicles were generated by adding 200 mM sucrose solution and applying a low
frequency AC field using a function generator (sine function, 10 Hz, 1.5 V) for
1.5 h at a temperature of 45 °C. The samples were collected and 50 μl of vesicles
was added to 250 μl of 200 mM glucose solution in each of the microscopy
chambers (Lab-tek Brand Products, Naperville IL). Because of the density
differences between the inside and outside of the vesicles, the vesicles sink to the
bottom of the chambers few minutes after adding the GUVs into the chamber.
Subsequent observation of the GUVs were done in an inverted confocal
fluorescence microscope (Zeiss-LSM 510 META NLO, Carl Zeiss, Jena,
Germany). The objective used for these experiments was a 40× water immersion
with a NA of 1.2. Laser lines at 488 and 543 nm were used for excitation of
BODIPY® FL PI(4,5)P2 and BODIPY® TMR PI(4,5)P2 respectively. In the
FRET experiments excitation was at 488 nm and the observation of the
BODIPY-FL fluorescence was through a bandpass BP 510-530IR filter. Time
series were obtained for the GUV consisting of 40 images taken with 1.84 s
intervals. Two regions of the membrane at the equator of the vesicles were
Fig. 3. (A) Effect of PI(4,5)P2 concentration on the light scattering intensity. The
normalized scattering intensities (see Materials and methods) for unlabeled PI
(4,5)P2 were obtained at 330 nm (◊) and 350 nm (○). The breaking point
corresponds to concentrations of 30–45 μM. (B) Dynamic light scattering
results showing PI(4,5)P2 aggregate compatible with the size of micelles for
29 μM (black bars) and 56 μM (grey bars) concentrations and no such
aggregates at 21 μM (dark grey bars).
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subtraction. All three regions were of the same size. Changes in the fluorescence
intensity with time was recorded for BODIPY® FL PI(4,5)P2 in presence and
absence of BODIPY® TMR PI(4,5)P2 and profilin.
3. Results
3.1. PI(4,5)P2 micelles critical concentration
In order to verify that 1 μM of PPI lipids was indeed below
the critical micelle concentration, we followed the formation of
micelles in solution using light scattering. The concentration of
unlabeled PI(4,5)P2 was varied from 1 μM to 1 mM. While the
absorption of the sample varied linearly with the concentration
(Fig. 2), the normalized scatter shows no changes in intensity up
to 30–40 μM but a sudden decrease in scattering intensity is
observed at concentrations above that threshold (Fig. 3A). The
30–40 μM threshold is in very good agreement with the 30 μM
critical micelle concentration (CMC) reported for PI(4,5)P2
lipids by Palmer [26] and is compatible with the CMC estimated
by the coomassie blue method of 10 μM by Huang and Huang
[27] and the CMC of 12.5 μM obtained using DPH [28] There
was no difference in this result using scattering observed at
330 nm or at 350 nm. The decreasing scatter intensity with
increasing micelles concentration is attributed to an increased
inner filter effect. This inner filter effect is due to the cuvette
geometry. Since the light path toward the detector is 2.5 times
longer than the light path on the excitation side, the scattered
light will have a higher probability of being scattered multiple
times after the initial scattering event and therefore would have
less chances of reaching the detectors. This would result in a
decrease of scattering intensity.
We confirmed these measurements using dynamic light
scattering. PI(4,5)P2 micelles were observed for PI(4,5)P2
concentrations of 56 μM and 29 μM (Fig. 3B), but the scattering
signal was too low to assign any aggregate size for concentra-
tion of 21 μM and below. We verified that the absence ofFig. 2. Changes in optical density of unlabeled PI(4,5)P2 lipids as a function of
concentration. The open diamonds (◊) represent the data obtained at 295 nm.
The open circles (○) represent the data obtained at 330 nm. The solid lines are
the linear fits of the data.assignment was not the result of a lack of sensitivity of the
instrument by detecting micelles formed using di-block acrylic
acid-8-styrene raft (MW 1648 Da) at a concentration of 6 μM
(data not shown).
We then looked at the anisotropy when the concentration of
BODIPY® TMR PI(4,5)P2 is varied from 500 μM to 1 nM. A
very low anisotropy (r) of 0.0245±0.0026 (mean±stdev) was
observed with no concentration dependence (data not shown).
Furthermore, the same anisotropy was observed for BODIPY®
TMR PI(4,5)P2:unlabeled PI(4,5)P2 micelles with molar ratios
of 1:100 and 1:1000. This observation suggests that the
BODIPY® TMR moiety attached to the sn-1-O-acyl chain of
the PI(4,5)P2 molecule interferes with the packing of the lipids
in micelles and that the labeled PPI lipids do not incorporate or
form micelles at least up to a concentration of 500 μM.
An alternate explanation could be that there is enough
disorder in the micelle that the label would freely rotate even
when in a micelle. However, this latter explanation is unlikely
for the following reasons. For solutions containing a 1:100
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BODIPY® TMR PI(4,5)P2 molecules. Due to the proximity of
the BODIPY® TMRmoieties within these micelles and the high
Ro value (56.3 Å) for homo-FRET [22], we would expect a high
efficiency of homo-FRET to occur. This homo-FRET would
result in a decrease in anisotropy [29]. Upon dilution, there
would be an increase in anisotropy resulting from a decrease in
FRET efficiency. Such increase in anisotropy was not observed.
To further investigate the state of the labeled PI(4,5)P2
molecules below micellar concentration, we performed hetero-
FRET experiments between BODIPY® FL and BODIPY®
TMR moieties. We prepared two solutions of 1 μM (1 ml each)
of BODIPY® FL PI(4,5)P2 and BODIPY® TMR PI(4,5)P2,
respectively. The emission spectrum of these two solutions were
recorded and these two spectra (without FRET) were added
(Fig. 4A). This was followed by the addition of 1 μL of a 1 mM
solution of the BODIPY® TMR PI(4,5)P2 or the BODIPY® FL
PI(4,5)P2 in the BODIPY® FL PI(4,5)P2 and BODIPY® TMR
PI(4,5)P2 solutions, respectively. The emission spectrum of
BODIPY® TMR PI(4,5)P2-BODIPY® FL PI(4,5)P2 andFig. 4. Steady state fluorescence intensity of BODIPY® FL PI(4,5)P2 and
BODIPY® TMR PI(4,5)P2. (A) Dotted line (. . .): Fluorescence emission
spectrum of 1 μMBODIPY® FL PI(4,5)P2. The fluorescence emission spectrum
of 1 μM BODIPY® TMR PI(4,5)P2 is represented by the dashed line (– – –).
The solid line is the sum of the two spectra. (B) FRET efficiency between the
acceptor and donor labeled PIP(4,5)P2. The dashed line (– – –) represents the
spectrum obtained for BODIPY® TMR PI(4,5)P2-BODIPY® FL PI(4,5)P2. The
dot-dot-dashed line (· · –) represents the spectrum obtained for BODIPY® FL
PI(4,5)P2-BODIPY® TMR PI(4,5)P2. The solid line is the sum of the two
spectra without FRET from A. above. The insert is the differential in %
between the sum of the two spectra without FRET and BODIPY® TMR PI(4,5)
P2-BODIPY® FL PI(4,5)P2, dashed line (– – –) and BODIPY® FL PI(4,5)P2-
BODIPY® TMR PI(4,5)P2, dot-dot-dashed line (· · –).BODIPY® FL PI(4,5)P2- BODIPY® TMR PI(4,5)P2 solutions
were then recorded. No significant changes in intensities of the
donor could be detected (Fig. 4B) in either solutions. A small
increase of the emission of the BODIPY® FL PI(4,5)P2-
BODIPY® TMR PI(4,5)P2 sample was observed (4%).
However, since this is not correlated with a decrease in the
donor emission, it probably results from the addition of
concentrated BODIPY-TMR PI(4,5)P2 to the BODIPY® FL
PI(4,5)P2 solution. The absence of FRET demonstrate that for
concentrations of 2 μM labeled PI(4,5)P2, the molecules do not
form aggregates and are mostly mono-dispersed. Indeed, in the
case of a dimer, assuming a random association of the
BODIPY® FL PI(4,5)P2 and BODIPY® TMR PI(4,5)P2
molecules, we will have three population of dimers, one with
donor probes only, one with acceptor probes only and the third
one with donor–acceptor probes. Only the donor–acceptor
solutions will results in FRET efficiency. Assuming a molecule
length of ∼40 Å, and using Eq. (6), we can calculate the
expected efficiency of transfer for these dimers. If the
monomers in the dimer are parallel, the efficiency of transfer
would be >99% while if the monomers are anti-parallel, the
efficiency of transfer would be >97%. The probability of the
mixed donor–acceptor probe dimers is 50% when the same
concentration of acceptor and donor labeled lipids are mixed in
equal amount. Using Eq. (7), the expected efficiency of energy
transfer for the solution would be ∼50% if the monomers in the
dimers are parallel and∼48% if the monomers in the dimers are
anti-parallel, i.e. with the probes on opposite side of the dimers.
Higher aggregates for instance tetramers would result in even
more FRET [30]. Since we could not detect FRET, we can
conclude that most if not all of the labeled PI(4,5)P2 lipids are
mono-dispersed and do not form aggregates at concentrations
below 2 μM. However, this finding may not be true for the
unlabeled PI(4,5)P2 which might form aggregates at these
concentrations since they have longer fatty acid chains and are
less water soluble than the BODIPY labeled PPI.
3.2. Anisotropy of PPI:profilin complex
The anisotropy data for BODIPY® TMR PI(4,5)P2 and
BODIPY® TMR PI(3,4,5)P3 in the presence of profilin at
concentrations ranging from 6 μM to 950 μM are presented in
Fig. 5. The data obtained with profilin from outdated platelets
or from the expression of Human profilin in bacteria were
similar and therefore were considered together. The anisotropy
of the PPI:profilin complexes decreased with decreasing
profilin concentration and reached values similar to the
anisotropy of the free BODIPY® TMR PI(4,5)P2. We also
note that the anisotropy values for the BODIPY® TMR PI
(3,4,5)P3:profilin complexes are higher than those obtained for
BODIPY® TMR PI(4,5)P2 suggesting a lower dissociation
constant for PI(3,4,5)P3.
To ascertain that the binding is not due to the BODIPY®
TMR probe interacting directly with profilin, the anisotropy of
another labeled phosphoinositide was measured complexed
with profilin: BODIPY® FL PI(4,5)P2. Having very different
chemistry, it is unlikely that the fluorescent labels i.e. BODIPY®
Fig. 6. (A) Anisotropy data for the binding of BODIPY® TMR PI(4,5)P2 and
BODIPY® FL PI(4,5)P2 with profilin. The labeled PPI concentration was kept
constant at 1μM. The open squares (□) represent the data obtained for
BODIPY® TMR PI(4,5)P2 while the filled circles (●) are the data obtained for
BODIPY® FL PI(4,5)P2. Lower anisotropy values are the results of a
combination of lower molecular size and longer lifetime. The solid lines are
the fit of the data using a KD value of 985 μM. (B) Multifrequency phase and
modulation data obtained for BODIPY® TMR PI(4,5)P2 and BODIPY® FL PI
(4,5)P2. The filled symbols are the phase (●) and modulation (■) data,
respectively, measured for BODIPY® TMR PI(4,5)P2. The open symbols
represent the phase (○) and modulation (□) data, respectively, determined for
BODIPY® FL PI(4,5)P2. The solid lines are the fit of the phase and modulation
data.
Fig. 5. Anisotropy data for the binding of BODIPY® TMR labeled PPI lipids
with profilin. The labeled PPI concentration was kept constant at 1 μM. The
filled circles (●) are the data obtained for BODIPY® TMR PI(4,5)P2. The open
triangles (▵) are the data obtained for BODIPY® TMR PI(4,5)P2 using profilin
purified from Human platelets. The open circles (○) represent the data obtained
with BODIPY® TMR PI(3,4,5)P3. The solid lines are the fit of the data using an
estimated anisotropy value for the lipid bound to profilin of 0.20. The calculated
KDs are 985 μM (r
2=0.993) and 720 μM (r2=0.983) for BODIPY® TMR
PI(4,5)P2 and BODIPY® TMR PI(3,4,5)P3, respectively.
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affinity. These results are presented in Fig. 6. It is clear that the
concentration range at which profilin binds to the PPI lipids is
the same independent of the fluorophores.
We also verified that profilin does not form aggregates at
high concentration which would result in an overestimation of
the anisotropy of the PPI/profilin complex. We determined the
anisotropy of profilin alone using the fluorescence of the
intrinsic tryptophan and could not detect any increase of the
anisotropy (mean±SEM; 0.0667±0.0012) up to 840 μM. A
slight increase in anisotropy is detected for higher concentration
(r=0.0772 for 1650 μM profilin) which indicate that profilin
starts to form aggregates at concentrations higher than 840 μM.
This formation of aggregates could modify the observed
anisotropy in two ways. If the aggregation does not prevent
the binding of mono-dispersed PPI to profilin, the anisotropy
would be overestimated. This could explain the slight deviation
of the anisotropy from the fitted curve for the binding of mono-
dispersed PI(3,4,5)P3 with high concentration of profilin (Fig. 5,
open circle last point). If on the other hand the aggregation of
profilin prevents the binding of mono-dispersed PPI, then the
observed anisotropy should decrease to a plateau. Such a
decrease was not observed.
In order to determine the dissociation constant (KD) of the
PPI/profilin complex, the anisotropy of BODIPY® TMR bound
to PPI must be determined. However, to achieve nearly
complete binding, profilin concentrations would have to be at
least a factor of 10 higher than that available here. This value
was thus estimated as described below. The correct quantitative
relation between the polarization, the excited state lifetime, the
size of the fluorophore and the viscosity of the medium was
described by F. Perrin in 1926 [31] [for a recent review see
Jameson et al. [29]].
The Perrin equation in terms of anisotropy is:
r0=r ¼ ð1 þ s=scÞ ð8ÞWhere r is the anisotropy, r0 is the limiting anisotropy (in
absence of rotation), τ is the excited state lifetime of the
fluorophore and τc the rotational correlation time.
Assuming that the molecule is spherical, τc is equal to:
sc ¼ gMðυ þ hÞ=RT ð9Þ
where η is the viscosity of the medium, M is the molecular
weight, υ is the partial specific volume, h the degree of
hydration, R is the universal gas constant and T the absolute
temperature. Using the molecular weight of the profilin PPI
lipid complex, the rotational correlation time can be estimated to
be ∼7 ns for BODIPY® TMR PI(4,5)P2 and BODIPY® TMR
PI(3,4,5)P3 and ∼6.6 ns for BODIPY® FL PI(4,5)P2. The
limiting anisotropies of the probes were determined using 1 μM
of labeled PPI lipids in anhydrous glycerol at 0 °C. Values of
0.365±0.001 and 0.353±0.002 were obtained for BODIPY®
TMR PI(4,5)P2 and BODIPY® FL PI(4,5)P2, respectively.
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anisotropy value of 0.37 reported by Karolin et al. [32]. One
more parameter needs to be measure in order to estimate the
anisotropy value of the bound labeled PPI, namely the life-
times of the BODIPY® TMR and BODIPY® FL labeled
phospholipids.
3.3. Lifetimes of BODIPY® TMR PI(4,5)P2 and BODIPY® FL
PI(4,5)P2
The lifetimes of the two fluorophores were measured both
with the PPI free in solution and bound with 387 μM of
profilin for BODIPY® FL PI(4,5)P2 and 733 μM of profilin
for BODIPY® TMR PI(4,5)P2. In each case, the best fit was
always obtained for a single discrete exponential decay.
Furthermore, there are no differences in lifetimes between the
labeled phospholipids free in solution or bound to profilin
(Fig. 1). The data for the lifetimes of BODIPY® TMR PI
(4,5)P2 and BODIPY® FL PI(4,5)P2 are shown in Fig. 6B.
A lifetime value of 5.1 ns (χ2 =3.5) was obtained for
BODIPY® TMR and a slightly longer lifetime of 5.9 ns
(χ2 =6.4) was obtained for BODIPY® FL. Reduced χ2
values were calculated using nonlinear least-squares analysis
assuming standard phase and modulation errors of 0.2° and
0.004, respectively, as described in Jameson et al. [33] These
lifetimes are in good agreement with those reported by
Karolin et al. [32].
3.4. Dissociation constant of the labeled PPI
Using the Perrin equation, a value of 0.20±0.05 was then
estimated for the anisotropy of the BODIPY® TMR PPI bound
to profilin and a value of 0.18±0.05 for the anisotropy of the
BODIPY® FL PPI bound to profilin.
The data from Figs. 5 and 6Awere fit using nonlinear curve
fitting (SigmaPlot) and dissociation constants of labeled PPI
with profilin were obtained. The solid lines in Fig. 5 represent
the fit for KD values of 720±40 μM and 985±40 μM for sub-
micellar concentration of PI(3,4,5)P3 and PI(4,5)P2, respec-
tively. The curve fitting on Fig. 6A was obtained with the PI
(4,5)P2 KD value of 985 μM.Fig. 7. Partitioning of the BODIPY® FL PI(4,5)P2 and BODIPY® TMR PI(4,5)P2 in
(B) POPCGUV containing 0.1 mol% BODIPY® TMR PI(4,5)P2. (C) GUV formed of
three pictures are taken at the equatorial plane of the vesicles.3.5. Binding of profilin to BODIPY® TMR PI(4,5)P2 and
BODIPY® FL PI(4,5)P2 in a membrane model system:
the GUV
In order to test that despite the low binding affinity of profilin
for submicellar concentration of PPI, profilin bind to the
BODIPY® labeled lipids incorporated in a membrane, we
investigated the changes in FRET between BODIPY® FL PI
(4,5)P2 and BODIPY® TMR PI(4,5)P2 in GUVs composed of
POPC. GUV's have at least two advantages over micelles, small
unilamellar vesicles and large unilamellar vesicles. They have a
membrane curvature similar to cells and they are visible in the
microscope.
Both BODIPY® FL PI(4,5)P2 and BODIPY® TMR PI(4,5)
P2 do not partition easily into the POPC membrane. Partitioning
was only obtained for 1% BODIPY® FL PI(4,5)P2 and 0.1%
BODIPY® TMR PI(4,5)P2 (Fig. 7A, B). When BODIPY® FL
PI(4,5)P2 and BODIPY® TMR PI(4,5)P2 were both present in
the membrane, partitioning was obtained for 0.25% of each of
the labeled lipid. Also, when GUV's were formed of POPC/
unlabeled PI(4,5)P2 10:1 mol, the labeled PI(4,5)P2 did not
partitioned to the membrane (Fig. 7C). Lack of partitioning of
these short (C6) BODIPY® labeled PPI to the membrane has
been previously reported by Cho et al. who noticed that these
lipids were not well localized to the surface membrane and were
equally found in the cytoplasm [34].
Donor photobleaching [35] was used to investigate the
FRET between the BODIPY® labeled lipids in the GUV. Due to
the large R0 values for either homo-FRET or hetero-FRET
(>50 Å) and at the lipids concentration used, FRET and hence
resistance of the BODIPY® FL PI(4,5)P2 to photobleaching is
present even in absence of profilin. Quantification of the FRET
efficiency was however not possible. Indeed, in order to
quantify the FRET efficiency, one needs to obtain on the same
vesicle the bleaching rate of the donor labeled lipid only. It is
possible to achieve this by photobleaching the acceptor probe
and then looking at the rate of photobleaching of the donor in
two areas of the membrane; one where the acceptor is present
and one where the acceptor has been photobleached. The latter
gives the rate of photobleaching for the donor labeled lipid only.
However, due to the high diffusion rates of the BODIPY®the POPC GUVs. (A) POPC GUV containing 1 mol% BODIPY® FL PI(4,5)P2.
POPC/unlabeled PI(4,5)P2 10:1 mol with 1 mol% BODIPY® FL PI(4,5)P2. The
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the bleaching of the acceptor labeled lipid was not possible.
Also, because of the different donor labeled PI(4,5)P2 con-Fig. 8. Effect of profilin binding to the photobleaching rate of BODIPY® FL PI(4,5)P2
P2 and 0.25% BODIPY® TMR PI(4,5)P2 in absence of profilin. (B) Photobleaching o
of the GUV showed in panel A in presence of 90 μM profilin. (D) Decrease in fluore
GUV containing 0.25% BODIPY® FL PI(4,5)P2 and 0.25% BODIPY® TMR PI(4,5
function of time for a POPC GUV containing 1% BODIPY® FL PI(4,5)P2. The filled
the data obtained for the GUVs in presence of 20 μM profilin and the filled triangles
bars are the SEM.centration between the GUV's containing donor only (1%) and
donor in presence of acceptor (0.25%), it was not possible to
obtain the rate of photobleaching of the donor only at 0.25%. (A) Photobleaching of the POPCGUV containing 0.25%BODIPY® FL PI(4,5)
f the GUV showed in panel A in presence of 20 μM profilin. (C) Photobleaching
scence intensity of the BODIPY® FL PI(4,5)P2 as a function of time for a POPC
)P2. (E) Decrease in fluorescence intensity of the BODIPY® FL PI(4,5)P2 as a
circles (●) are the data obtained in absence of profilin. The open circles (○) are
(▼) are the data obtained for the GUVs in presence of 90 μM profilin. The error
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Therefore, the data were only analyzed qualitatively. Fig. 8
shows the rate of the donor labeled PI(4,5)P2 photobleaching in
absence and presence of profilin for donor only and donor with
acceptor labeled PI(4,5)P2. There is a clear increase in the
BODIPY® FL PI(4,5)P2 rate of photobleaching in presence of
profilin and this change is larger at higher profilin concentration
(90 μM) showing that profilin interact with the labeled PI(4,5)
P2 in the GUV lipid bilayer.
4. Discussion
In the last 15 years, several authors studied the binding of
profilin to PI(4,5)P2 and/or PI(3,4,5)P3 micelles using the
changes in fluorescence intensity of profilin's tryptophan upon
PPI binding [15,18,36]. Our scattering data were obtained at the
wavelength corresponding to the emission wavelength of
tryptophan residues used in these previous studies. We showed
in this paper that above the critical micelle concentration of
around 30 μM, there is an increased inner filter effect with the
increase in PI(4,5)P2 concentration. Therefore, we can expect
that at least part of the decrease of the tryptophan fluorescence
observed upon increased concentration of PPI micelles will be
due to this inner filter effect. In the present study, we used
cuvettes with a shorter path length than the conventional
10×10 mm cuvette. The sizes of the cuvettes used in the
previous studies are unfortunately not reported. However, if
these fluorescence intensity experiments were done in
10×10 mm cuvettes, then the inner filter effect reported here
would be even larger.
Some of the previous binding experiments between profilin
and PPI micelles, were obtained using a range of PPI
concentrations that overlapped the transition between sub-
micellar and micellar lipids [15,36] i.e. ranging from 0.5 to
95 μM [15] and from 9 to 45 μM PI(4,5)P2 [36]. The overlap
with the micellar transition would probably not be an issue if the
dissociation constant between sub-micellar concentration of PPI
lipids and profilin was the same as the dissociation constant
obtained with micellar PPI lipids. Since there is at least a 30 fold
difference in the dissociation constant between profilin and
micellar or sub-micellar concentration of PPI lipids, these
published data cannot be used to determine the dissociation
constant between profilin and PI(4,5)P2 or PI(3,4,5)P3 micelles.
Indeed, the data will be contaminated with the low binding
affinity for sub-micellar lipids as well as with the transition
phase into micelles.
From our experiments, it is difficult to determine whether the
interaction between profilin and the PPI lipids occur through the
hydrophobic tail or the negatively charged head of the
phospholipids. However, we can probably exclude the interac-
tion of profilin with the fluorophore moiety. Indeed, we do not
detect any changes in the fluorescence lifetimes and therefore
quantum yields of the two fluorophores used when profilin
binds to the PPI. Also, in the case of binding to the fluorophore,
we would expect to obtain a different dissociation constant
between the BODIPY® TMR PI(4,5)P2 and BODIPY® FL PI
(4,5)P2 due to the different chemistry of the fluorophores. Sucha difference was not observed. The difference in anisotropy for
the BODIPY® FL PI(4,5)P2 compared to BODIPY® TMR PI
(4,5)P2 is due to a smaller size of the molecule together with the
longer lifetime of the fluorophore.
In addition, our data demonstrate a lower dissociation con-
stant for BODIPY® TMR PI(3,4,5)P3 compared to BODIPY®
TMR PI(4,5)P2, which strongly suggests that profilin is indeed
interacting with the negatively charged phosphates of the
phospholipids heads and not with the hydrophobic tail or the
fluorophore.
In our estimation of the anisotropy of lipids bound to profilin
(rB), we assumed a spherical protein lipid complex. Jameson
and Seifried [37], discussed the effect on the polarization/
anisotropy when the shape of the molecule deviates from the
spherical model. Such deviation would result in an increased
value of the polarization/anisotropy of the complex and
therefore an increased value of the dissociation constant.
Lassing and Lindberg initially showed that the packing of the
lipid can determine the efficiency of the dissociation of the
profilin:actin complex by PI(4,5)P2 [38]. Also, these authors, in
one of their early works on the interaction between profilin:actin
and PI(4,5)P2 [16], showed that in their experimental conditions
soluble inositol (1,4,5) trisphosphate did not dissociate the
profilin:actin complex and did not prevent the dissociation of
the profilin:actin complex by PI(4,5)P2. Lassing and Lindberg
suggested that in order to form a stable complex, profilin has to
interact with the phosphorylated inositols of at least two
adjacent PPI molecules. Later, Goldschmidt-Clermont et al. [17]
demonstrated using large unilamellar vesicles (LUVET), that
each profilin molecules protected approximately 5 PI(4,5)P2
molecules from hydrolysis by phospholipase C. These authors
proposed that profilin could aggregate PI(4,5)P2 into small
patches. Our data support the hypothesis that the initial
interaction of profilin with the PPI lipids could require more
that one PPI and/or that the membrane is an essential component
of the profilin interaction with PPI. Our GUV data also suggest
that profilin is able to recruit adjacent PPI lipids. Indeed, as
illustrated by the schematic drawing in Fig. 9, in absence of
profilin, the donor and acceptor labeled PPI could be distributed
across the membrane (Fig. 9A). As the R0 value for the probe
pair is around 74 Å, this would result in a significant level of
FRET thus partially protecting the donor from photobleaching.
When profilin is added, recruitment of PPI by profilin will have
two effects (Fig. 9B). Firstly, the efficiency of transfer between
the labeled PPI clustered around profilin would dramatically
increase to >90%, thus protecting the donor from photobleach-
ing but also reducing the donor fluorescence intensity
dramatically. Secondly, the donor labeled PPI that are not
recruited by profilin will have a reduction in FRET efficiency,
resulting in higher initial fluorescence intensity but also a much
higher susceptibility to photobleaching. This model could
explain the biphasic shape of the donor photobleaching curve
observe in presence of profilin in Fig. 8. Also, in the case of the
donor only control there is initially more BODIPY® FL labeled
PI(4,5)P2 in the membrane; 1% compared to 0.25%, which
would result in homo-FRET, thus protecting the BODIPY® FL
labeled PI(4,5)P2 from photobleaching. In presence of profilin,
Fig. 9. Model of profilin interaction with the BODIPY® labeled PI(4,5)P2. (A)
In absence of profilin, the BODIPY® labeled PI(4,5)P2 are distributed randomly
in the leaflets of the lipid bilayer. Due to the large R0 values for the probe pairs,
FRET (represented by the dotted arrows) occurs between the donor and acceptor
probes, protecting the donor from photobleaching. (B) In presence of profilin,
the BODIPY® labeled PI(4,5)P2 are clustered by profilin increasing the FRET
efficiency between the donor and acceptor in the cluster to >90% resulting in a
large decrease in donor intensity. The clustering isolates some of the donor
labeled PI(4,5)P2 which do not participate in FRETanymore, the initial intensity
of these donor probes is higher but they are now much more susceptible to
photobleaching.
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decrease as dramatically as observed for the GUV containing
both BODIPY® FL PI(4,5)P2 and BODIPY® TMR PI(4,5)P2
because of the significant homo-FRET in the cluster.
Studies on Gelsolin, another PI(4,5)P2 binding protein has
been shown to depend on the mole fraction of PI(4,5)P2 in
phosphatidylcholine vesicles [39,40].When the mole fraction of
PI(4,5)P2 fall below 5 to 10% of the membrane lipids
composition, Gelsolin becomes insensitive to PI(4,5)P2. This
is in contrast with the results obtained with GUV and profilin.
Indeed, binding of profilin to the PI(4,5)P2 in the GUV
membrane was observe for a molar fraction of PI(4,5)P2 of only
0.5% of the lipids in the GUVs. This could reflect a difference in
the mechanism of interaction between the PPI and the two
proteins, profilin and gelsolin or a difference inherent of the
model system used, GUV compared to liposomes.
Ostrander et al. [12] reported that, in yeast, profilin binding
to PI(4,5)P2 lipids followed surface dilution kinetics. These
authors examined the dependence of the surface concentration
of PI(4,5)P2 and found that the binding of profilin was indeed
dependent on the surface concentration and that this binding
appeared cooperative with a Hill coefficient of 2.
Since in human erythrocytes, the PI(4,5)P2 lipids is thought
to represent only 1% of the total lipids of the membrane [41],the difference in binding between profilin and gelsolin may
have physiological significance. Indeed, PI(4,5)P2 clusters
could be essential to allow interactions with proteins such as
gelsolin but might not be so crucial for profilin. In Acantha-
moeba castellanii, immunofluorescence experiments localized
PI(4,5)P2 associated with the plasma membrane and particularly
at the leading edge of migrating cells [42]. Such localization to
specific regions of the cells, would result in a local increase in PI
(4,5)P2 concentration which might be sufficient to induce the
initial association of profilin to PPI lipids. High local
concentrations of PI(4,5)P2 could also arise from the localized
production of PI(4,5)P2 by the type I PIP kinases [43,44]. Using
pleckstrin-homology (PH) domain fused to green fluorescent
protein (GFP) as a probe for PI(4,5)P2 in NIH-3T3 fibroblasts
Tall et al. [45] revealed intense, non-uniform fluorescence in
distinct structures at the cell periphery. These authors identified
these structures as ruffles and microvillus-like protrusions.
Doughman et al. suggested that these local increase in PI(4,5)P2
levels induces actin remodeling [44]. These local enrichments
of PI(4,5)P2 might be sufficient to allow for the binding of
profilin to the membrane and the sequestration of PI(4,5)P2 by
profilin or vice versa. Profilin:actin after catalyzing the
exchange of ADP for ATP in the actin cleft, could bind to PI
(4,5)P2. The recruitment of additional PI(4,5)P2 by profilin
would release actin from profilin which can then be incorpo-
rated into growing actin filaments. Profilin remaining bond to
the PI(4,5)P2 lipids, would then protect PI(4,5)P2 from hydroly-
sis by phospholipase C-γ1 [17].
The data presented here, clearly demonstrate the need for
a better understanding of the processes driving the binding of
profilin to the membrane and the factors that could affect
this association. Experiments are underway to address these
questions.
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